No Prescription |
 |
 | ||
|
Aricept Generic Donepezil |
|
| ||
No Prescription » Prescription Drugs 2 » Aricept Generic Donepezil Product Origin: EU (Turkey) This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English. Medical Information: Aricept is used for: Treating mild to moderate dementia (eg impairment of memory judgment and abstract thinking; changes in personality) caused by Alzheimer disease. Donepezil (doe-NEP-ah-zil) is used to treat the symptoms of mild to moderate Alzheimer's disease. Donepezil will not cure Alzheimer's disease and it will not stop the disease from getting worse. However it can improve thinking ability in some patients. Donepezil improves the function of nerve cells in the brain. It works by preventing the breakdown of a chemical called acetylcholine (ah see til KO leen). People with dementia usually have lower levels of this chemical which is important for the processes of memory thinking and reasoning Aricept is one of the few drugs that can provide some relief from the symptoms of early Alzheimer's disease. (Cognex Exelon and Reminyl are others.) Alzheimer's disease causes physical changes in the brain that disrupt the flow of information and interfere with memory thinking and behavior. Buy Aricept Generic Donepezil and other Prescription Drugs 2 products online at Medstore. Buy Online at Medstore - Click Here!
About Aricept Generic Donepezil: Product Type: Prescription Drugs 2 Aricept ( Generic Donepezil ) Aricept (Generic Donepezil) Generic Donepezil 10mg 28 Tablets 5mg 14 Tablets Generic Donepezil Aricept
View more Prescription Drugs 2 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
